Holdings
Nomura Healthcare Fund
As of Jun 30, 2026, Nomura Healthcare Fund reported 92 positions worth US$692M. Largest: Ucb S.a., Abbvie Inc. and Eli Lilly And Company. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Ucb S.a. | 130K | US$39M | no change | Jun 30, 2026 |
| Abbvie Inc. | 125K | US$31.5M | no change | Jun 30, 2026 |
| Eli Lilly And Company | 26,000 | US$31.2M | no change | Jun 30, 2026 |
| Regeneron Pharmaceuticals, Inc. | 47,000 | US$29.3M | no change | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 70,000 | US$29.1M | no change | Jun 30, 2026 |
| Pfizer, Inc. | 1.2M | US$28.8M | +50,000 | Jun 30, 2026 |
| Merck & Company, Inc. | 215K | US$27.6M | no change | Jun 30, 2026 |
| Gilead Sciences, Inc. | 210K | US$26.5M | no change | Jun 30, 2026 |
| Astrazeneca Plc | 131K | US$24.5M | no change | Jun 30, 2026 |
| Elevance Health, Inc. | 63,000 | US$24.4M | no change | Jun 30, 2026 |